<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cure CMD &#187; admin</title>
	<atom:link href="http://curecmd.org/archives/author/admin/feed" rel="self" type="application/rss+xml" />
	<link>http://curecmd.org</link>
	<description>Cure CMD provides Congenital Muscular Dystrophy resources, information, and support to families, doctors, and researchers.</description>
	<lastBuildDate>Wed, 08 Feb 2012 23:26:05 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
		<item>
		<title>Podcast: Stephen Tapscott Discusses Role of DUX4 in FSHD</title>
		<link>http://quest.mda.org/news/podcast-stephen-tapscott-discusses-role-dux4-fshd</link>
		<comments>http://quest.mda.org/news/podcast-stephen-tapscott-discusses-role-dux4-fshd#comments</comments>
		<pubDate>Fri, 03 Feb 2012 00:43:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[An 11½-minute interview with researcher Stephen Tapscott explores recent findings about the molecular basis of facioscapulohumeral MD]]></description>
			<content:encoded><![CDATA[An 11½-minute interview with researcher Stephen Tapscott explores recent findings about the molecular basis of facioscapulohumeral MD]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5100/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MDA Awards More Than $12 Million in Grants to Advance Neuromuscular Disease Research</title>
		<link>http://www.mda.org/research/120201grants.html</link>
		<comments>http://www.mda.org/research/120201grants.html#comments</comments>
		<pubDate>Thu, 02 Feb 2012 00:35:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[The Muscular Dystrophy Association's latest round of grants allocates more than $12 million to the support of 38 research projects investigating the causes of, and potential treatments for, a number of forms of neuromuscular disease.]]></description>
			<content:encoded><![CDATA[The Muscular Dystrophy Association's latest round of grants allocates more than $12 million to the support of 38 research projects investigating the causes of, and potential treatments for, a number of forms of neuromuscular disease.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5097/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jacobus Begins Invitation-Only Trial of 3,4-DAP in LEMS</title>
		<link>http://quest.mda.org/news/jacobus-begins-invitation-only-trial-34-dap-lems</link>
		<comments>http://quest.mda.org/news/jacobus-begins-invitation-only-trial-34-dap-lems#comments</comments>
		<pubDate>Wed, 01 Feb 2012 20:34:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Jacobus is inviting 30 selected individuals with Lambert-Eaton myasthenic syndrome to participate in a placebo-controlled trial of 3,4-DAP.]]></description>
			<content:encoded><![CDATA[Jacobus is inviting 30 selected individuals with Lambert-Eaton myasthenic syndrome to participate in a placebo-controlled trial of 3,4-DAP.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5043/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MDA Awards $2 Million in ALS Grants</title>
		<link>http://alsn.mda.org/news/mda-awards-2-million-als-grants</link>
		<comments>http://alsn.mda.org/news/mda-awards-2-million-als-grants#comments</comments>
		<pubDate>Wed, 01 Feb 2012 20:34:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[The grants fund six new ALS projects, each using a different mechanism to uncover the causes of the disease and potential treatments.]]></description>
			<content:encoded><![CDATA[The grants fund six new ALS projects, each using a different mechanism to uncover the causes of the disease and potential treatments.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5069/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MDA Commits $12 Million to Neuromuscular Disease Research</title>
		<link>http://quest.mda.org/news/mda-commits-12-million-nmd-research</link>
		<comments>http://quest.mda.org/news/mda-commits-12-million-nmd-research#comments</comments>
		<pubDate>Wed, 01 Feb 2012 20:34:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[MDA has awarded 38 grants totaling more than $12 million to support research into general muscle health and more than 15 neuromuscular diseases in its program.]]></description>
			<content:encoded><![CDATA[MDA has awarded 38 grants totaling more than $12 million to support research into general muscle health and more than 15 neuromuscular diseases in its program.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5068/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Phase 1 Trial Opens of ISIS-SMNRx in Children with SMA</title>
		<link>http://quest.mda.org/news/phase-1-trial-opens-isis-smnrx-children-sma</link>
		<comments>http://quest.mda.org/news/phase-1-trial-opens-isis-smnrx-children-sma#comments</comments>
		<pubDate>Mon, 23 Jan 2012 22:58:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Pharmaceuticals will test its experimental antisense drug in 24 children with spinal muscular atrophy at five U.S. centers.]]></description>
			<content:encoded><![CDATA[Pharmaceuticals will test its experimental antisense drug in 24 children with spinal muscular atrophy at five U.S. centers.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/4921/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indications of Safety, Efficacy in BrainStorm Stem Cell Trial</title>
		<link>http://alsn.mda.org/news/safety-efficacy-in-brainstorm-stem-cell-trial</link>
		<comments>http://alsn.mda.org/news/safety-efficacy-in-brainstorm-stem-cell-trial#comments</comments>
		<pubDate>Mon, 23 Jan 2012 22:58:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[NurOwn stem cell technology, currently being tested in Israel, appears safe and seems to improve breathing, swallowing and muscle strength.]]></description>
			<content:encoded><![CDATA[NurOwn stem cell technology, currently being tested in Israel, appears safe and seems to improve breathing, swallowing and muscle strength.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5041/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Immunosuppression Induces Tolerance to Enzyme Treatment in Pompe Disease</title>
		<link>http://quest.mda.org/news/immunosuppression-induces-tolerance-enzyme-treatment-pompe-disease</link>
		<comments>http://quest.mda.org/news/immunosuppression-induces-tolerance-enzyme-treatment-pompe-disease#comments</comments>
		<pubDate>Fri, 20 Jan 2012 18:23:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Four children not making any acid maltase enzyme tolerated enzyme replacement therapy when also treated with immunosuppressants.]]></description>
			<content:encoded><![CDATA[Four children not making any acid maltase enzyme tolerated enzyme replacement therapy when also treated with immunosuppressants.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5021/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nationwide Children&#8217;s Podcast Probes Exon Skipping in DMD</title>
		<link>http://quest.mda.org/news/podcast-probes-exon-skipping-dmd</link>
		<comments>http://quest.mda.org/news/podcast-probes-exon-skipping-dmd#comments</comments>
		<pubDate>Fri, 20 Jan 2012 18:23:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Molecular geneticist Stephen Wilton discusses his group's development of exon-skipping compounds to restore dystrophin production in Duchenne MD.]]></description>
			<content:encoded><![CDATA[Molecular geneticist Stephen Wilton discusses his group's development of exon-skipping compounds to restore dystrophin production in Duchenne MD.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5012/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MDA Funds Development of Utrophin &#8216;Magnet&#8217; for DMD/BMD</title>
		<link>http://quest.mda.org/news/mda-funds-utrophin-magnet-dmdbmd</link>
		<comments>http://quest.mda.org/news/mda-funds-utrophin-magnet-dmdbmd#comments</comments>
		<pubDate>Fri, 20 Jan 2012 18:23:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News from Other Sources]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[MDA's $1 million grant will help fund the development of TVN-102, which attracts the muscle protein utrophin to the muscle-fiber membrane.]]></description>
			<content:encoded><![CDATA[MDA's $1 million grant will help fund the development of TVN-102, which attracts the muscle protein utrophin to the muscle-fiber membrane.]]></content:encoded>
			<wfw:commentRss>http://curecmd.org/archives/5020/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

